Depressive symptoms and APOE polymorphisms in an elderly population-based sample

Psychiatric Genetics

Volumn 20, Issue 5, 2010, Pages 215-220

  García Peña, Carmen ^a   Juarez Cedillo, Teresa ^a   Cruz Robles, David ^b   Fragoso, José Manuel ^b   Sánchez García, Sergio ^a   Rodríguez Pérez, José Manuel ^b   Gallo, Joseph J ^c   Wagner, Fernando A ^d   Vargas Alarcón, Gilberto ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MORGAN STATE UNIVERSITY   (United States)

Author keywords

apolipoprotein E; depression; depressive symptoms; elderly; genetic susceptibility

Indexed keywords

APOLIPOPROTEIN E; PHOSPHODIESTERASE I;

ADULT; AGED; ALLELE; ANXIETY; ARTICLE; CONCENTRATION LOSS; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; THINKING IMPAIRMENT;

AGED; APOLIPOPROTEINS E; DEPRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 77957557065     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833a211a     Document Type: Article

References (37)

1. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997). Vascular depression hypothesis. Arch Gen Psychiatry 54:915-922.
2. Blazer DG, Burchett BB, Fillenbaum GG (2002). APOE epsilon4 and low cholesterol as risks for depression in a biracial elderly community sample. Am J Geriatr Psychiatry 10:515-520.
3. Cervilla J, Prince M, Rabe-Hesketh S (2004). Vascular disease risk factors as determinants of incident depressive symptoms: a prospective communitybased study. Psychol Med 34:635-641.
4. Cole MG, Dendukuri N (2003). Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 160:1147-1156.
5. Davignon J, Gregg RE, Sing CF (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
6. Eaton W, Muntaner C, Smith C (1998). Revision of the center for epidemiologic studies depression (CES-D) Scale. Baltimore: Johns Hopkins University, Prevention Center.
7. Ercoli L, Siddarth P, Huang SC, Miller K, Bookheimer SY, Wright BC, et al. (2006). Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease. Arch Gen Psychiatry 63:442-448.
8. Fan PL, Chen CD, Kao WT, Shu BC, Lung FW (2006). Protective effect of the apo epsilon2 allele in major depressive disorder in Taiwanese. Acta Psychiatr Scand 113:48-53.
9. Folstein MF, Folstein S, McHugh PR (1975). Mini-mental state: a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
10. Forsell Y, Corder EH, Basun H, Lannfelt L, Viitanen M, Winblad B (1997). Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75 +. Biol Psychiatry 42:898-903.
11. García-Peña C, Wagner F, Sánchez-Garcia S, Juárez-Cedillo T, Espinel-Bermúdez C, García-Gonzalez JJ, et al. (2008). Depressive symptoms among older adults in Mexico City. J Gen Int Med 23:1973-1980.
12. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, et al. (2006). Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 63:435-440.
13. Gorelick PB (2004). Risk factors for vascular dementia and Alzheimer disease. Stroke 35:2620-2622.
14. Hosmer DW, Lemeshow S (2000). Applied logistic regression. 2nd ed. New York: John Wiley & Sons.
15. Lehtonen R, Pahkinen E (2004). Practical methods for design and analysis of complex surveys (Statistics in Practice). 2nd ed. West Sussex: John Wiley & Sons LTD.
16. Liu CY, Hong CJ, Liu TY, Lin KN, Wang PN, Chi CW, et al. (2002). Lack of association between the apolipoprotein E genotype and depression in Alzheimer's Disease. J Geriatr Psychiatr Neurol 15:20-23.
17. Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, et al. (1997). Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 9:64-67.
18. Maloney B, Ge Y, Petersen R, Hardy J, Rogers J, Pérez-Tur J, Lahiri DK (2010). Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: differential effects in neuronal cells and on DNAprotein interactions. Am J Med Genet Part B 153:185-201. doi 10.1002/ajmg.b.30973.
19. Mauricio M, O'Hara R, Yesavage JA, Friedman L, Kraemer HC, Van De Water M, Murphy GM Jr (2000). A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry 8:196-200.
20. Menzel HJ, Kladetzky RG, Assmann G (1983). Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 3:310-315.
21. Morgan MD, Mielke MM, O'Brien R, Troncoso JC, Zonderman AB, Lyketsos CG (2007). Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA). Alzheimer Dis Assoc Disord 21:199-204.
22. Pedro-Botet J, Sentí M, Nogués X, Rubiés-Prat J, Roquer J, D'Olhaberriague L, Olivé J (1992). Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23:1556-1562.
23. Radloff LS (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1:385-401.
24. Rall SC, Weisgraber KH, Mahley RW (1982). Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 257:4171-4178.
25. Reyes-Ortega M, Soto-Hernández AL, Milla-Kegel JG, García-Ramírez A, Hubard-Vignau L, Mendoza-Sánchez H, et al. (2003). Actualización de la Escala de Depresión del Centro de Estudios Epidemiológicos (CES-D). Estudio piloto en una muestra geriá trica mexicana. Salud Mental 26:59-68.
26. Reyes de Beamn S, Beaman P, García-Peña C, Villa MA, Heres J, Córdova A, Jagger C (2004). Validation of a modified version of the Mini-Mental State Examination (MMSE) in Spanish. Aging Neuropsychol Cognition 11:1-11.
27. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern R, Dorkin HL, et al. (1993). Multiplex, PCR amplification from CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 2:159-163.
28. Sánchez-García S, Juárez-Cedillo T, García-González JJ, Espinel-Bermudez C, Gallo J, Wagner F, et al. (2008). Usefulness of two instruments in assessing depression among elderly Mexicans: in population studies and for primary care. Salud Publica Mex 50:447-456.
29. Sinoff G, Ore L, Zlotogorsky D, Tamir D (1999). Short anxiety screening test - a brief instrument for detecting anxiety in the elderly. Int J Geriat Psychiatry 14:1062-1071.
30. StataCorp (2005). Stata statistical Software: Release 9.0. College Station, TX: StataCorp LP.
31. Steffens DC, Norton MC, Hart AD, Skoog I, Corcoran C, Breitner JC; Cache County Study Group (2003). Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study. Psychol Med 33:541-547.
32. Traykov L, Bayle AC, Latour F, Lenoir H, Seux ML, Hanon O, et al. (2007). Apolipoprotein Eε4 allele frequency in elderly depressed patients with and without cerebrovascular disease. J Neurol Sci 257:280-283.
33. Utermann G, Hess M, Steinmetz A (1977). Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in men. Nature 269:604-607.
34. Vink D, Aartsen MJ, Schoevers RA (2008). Risk factors for anxiety and depression in the elderly: a review. J Affect Disord 106:29-44.
35. Weisgraber KH, Rall SC Jr, Mahley RW (1981). Human E apolipoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256:9077-9083.
36. Yen YC, Rebok GW, Yang MJ, Lung FW (2008). A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment. Prog Neuropsychopharmacol Biol Psychiatry 32:479-486.
37. Zietemann V, Zietemann P, Weitkunat R, Kwetkat A (2007). Relation between certain diseases and frequency of depression in geriatric patients. Nervenarzt 78:657-664.